EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations of urinary phthalate metabolite and replacement chemical concentrations with gestational blood pressure

Kimberly L Parra iD, Emma V Preston iD, Marlee R Quinn, Paige L Williams iD, Michele R Hacker, Thomas F McElrath iD, David E Cantonwine, Antonia M Calafat iD, Julianne Cook Botelho, Blair J Wylie, Camille E Powe, Ellen W Seely und 1 weitere

Journal of the Endocrine Society · 01.08.2026 · 10 (9)

DOI: 10.1210/jendso/bvag158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 13.07.2026. Verfasst von Kimberly L Parra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIDDK NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Some phthalates and their replacements are endocrine disrupting chemicals (EDCs) found in consumer products and linked to hypertensive disorders of pregnancy (HDP). Few studies have evaluated associations between EDCs and gestational blood pressure.

Objective

To evaluate associations between EDC biomarkers with gestational blood pressure.

Methods

The Environmental Reproductive and Glucose Outcomes study (N = 338) measured urinary concentrations of 18 phthalate and replacement metabolites and systolic (SBP) and diastolic (DBP) blood pressure at 3 pregnancy study visits (median: 12, 19, and 26 weeks’ gestation). Individual metabolite concentrations and summary measures based on common source or mechanism (eg, ΣPersonal care products [ΣPCP]) were log2-transformed, specific-gravity corrected, and modeled continuously and in quartiles. We estimated covariate-adjusted associations of individual metabolites and, summary measures with blood pressure using linear regression, and with HDP using log-binomial regression, assessing metabolite mixtures using Bayesian Kernel Machine Regression.

Results

HDP prevalence was 12.7%. Higher concentrations of monoethyl phthalate (MEP) and ΣPCP were most consistently associated with SBP and DBP elevations at visit 3. Higher concentrations of MEP (Q4 vs Q1) were associated with 4.59 mmHg higher SBP (95% CI: 0.04, 9.15), and higher ΣPCP (Q3 vs Q1) were associated with 5.78 mmHg (95% CI: 1.59, 9.97). Higher MEP and ΣPCP (Q4 vs Q1) were positively linked to DBP elevations of 4.51 to 4.70 mmHg. Other phthalate biomarkers were associated with blood pressure at specific time points.

Discussion

Certain urinary phthalate biomarkers, particularly MEP and ΣPCP, were associated with higher blood pressure levels in pregnancy, with implications for HDP.

Schlagwörter

Stichwörter der Autor:innen

blood pressureendocrine disruptorsgestational hypertensionhypertensive disorders of pregnancyphthalatespregnancy

Autor:innen und Institutionen

  • Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Division of Maternal Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

ORCID-Profile: Kimberly L Parra, Emma V Preston, Paige L Williams, Thomas F McElrath, Antonia M Calafat, Tamarra James-Todd

Förderung

  • NIEHS NIH HHS
  • NIDDK NIH HHS
  • NICHD NIH HHS
  • NCATS NIH HHS
  • National Institute of Environmental Health Sciences
  • NIH
  • Harvard Clinical and Translational Science Center

Zitieren

APA

Parra, K. L., Preston, E. V., Quinn, M. R., Williams, P. L., Hacker, M. R., McElrath, T. F., Cantonwine, D. E., Calafat, A. M., Cook Botelho, J., Wylie, B. J., Powe, C. E., Seely, E. W., & James-Todd, T. (2026). Associations of urinary phthalate metabolite and replacement chemical concentrations with gestational blood pressure. Journal of the Endocrine Society, 10(9). https://doi.org/10.1210/jendso/bvag158

Vancouver

Parra KL, Preston EV, Quinn MR, Williams PL, Hacker MR, McElrath TF, et al. Associations of urinary phthalate metabolite and replacement chemical concentrations with gestational blood pressure. Journal of the Endocrine Society. 2026;10(9). doi:10.1210/jendso/bvag158

BibTeX
@article{Parra2026,
  author = {Parra, Kimberly L and Preston, Emma V and Quinn, Marlee R and Williams, Paige L and Hacker, Michele R and McElrath, Thomas F and Cantonwine, David E and Calafat, Antonia M and Cook Botelho, Julianne and Wylie, Blair J and Powe, Camille E and Seely, Ellen W and James-Todd, Tamarra},
  title = {Associations of urinary phthalate metabolite and replacement chemical concentrations with gestational blood pressure},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  volume = {10},
  number = {9},
  doi = {10.1210/jendso/bvag158}
}
Kostenlos starten →